申请人:MERCK PATENT GMBH
公开号:US10669289B2
公开(公告)日:2020-06-02
Compounds of formula (I) are inhibitors of LMP7 and can be employed, inter alia, for the treatment of an autoimmune disorder or hematological malignancies.
式(I)化合物是 LMP7 的
抑制剂,可用于治疗自身免疫性疾病或血液恶性肿瘤等。